Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 477 50. Pharmbio Korea 1. Company Information Company Pharmbio Korea Representative Bong Kil, Nam E-mail mail@pharmbio.co.kr Representative Phone No. +82-2-587-2551~4 Representative Fax No. +82-2-523-9784 Hompage http://www.pharmbio.co.kr Address 1049-7 Sadang 1-dong, Dongjak-gu, Seoul, 156-827, KOREA Research Institute Address Year of Establishment 1999 Sales (‘06) 4.9 Million$ The Number of Employees (06‘) Total The Number of 49 Researcher (‘06) 0 Total Contact Person Hyun-Jung, Jung Contact Phone 82-2--587-2554 Contact E-mail pharmbio@hotmail.com Contact Fax 82-2-523-9784 Introduction of Company "We aim to become a company that helps the people who are suffering from disease and contributes public health." As each and every one of PBK family becomes one body, we are ceaselessly trying to make the world healthier without any diseases by researching and developing best quality product. Since the Korea's first urolithiasis treatment "UROCITRA" in 1999, we have made every effort to be a leading maker in the field of urologic medicines. As a result, we have marketed "UROCITRA" and another urolithiasis treatment "ROWATINEX" successfully. Moreover, we have developed and supplied "ROWACHOL" for cholelithiasis treatments and "HEPADIAL" for dyspepsia symptom of the patients with hepato-biliary diseases, and we are devoting ourselves in developing special products in the various kind of field and expanding markets. Promising to be a faithful company for public health, we wish this small space to supply new and necessary information for visitors. We wish you and your family all the best.
478 2007 Korea Pharmaceutical Industry Directory 2. Main Products Information No. The Name of Products Main Ingredient Use (Indications) Formulation The Date of Sales Expected Exporting Countries Etc. 1 UROCITRA Potassium citrate monohydrate Uric acid lithiasis with or without calcium stones tablet 2 ROWATINEX Pinene treatment of urinary tract spasm capsule 3 ROWACHOL Pinene treatment of hepato-biliary disorders capsule 4 HEPADIAL Magnesium dimecrotate treatment of difficult digestion. tablet 3. Patent Information No The Name of Technology Application No. (Application date) Publication No. (Publication date) Priority No. Applied Country For Global Development Stage Future Plan Expected Licencing (Domestic, Oversea) 1 THE METHOD OF PREPARING FOR URINARY CALCULUS LITHIASIS FOR TREATMENT 1999-0039110 (1999.09.13) 0379596 (2003.03.27) 2 The wax matrix tablet 2001-0019831 containing potassium (2001.04.13) citrate and its composition 0464592 (2004.12.22)
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
The Annex
Page 38 and 39:
316 2007 Korea Pharmaceutical Indus
Page 40 and 41:
The Korean Pharmaceutical Company L
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
4. Company Map The Korean Pharmace
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149: The Korean Pharmaceutical Company L
Page 200 and 201: 4. Company Map The Korean Pharmace
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

Create successful ePaper yourself

Delete template?

Save as template?